Sana Biotechnology, Inc. - Common Stock (NQ:SANA)

2.470 +0.110 (+4.66%)

Delayed Quote Updated: 4:00 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sana Biotechnology, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

2 Growth Stocks That Jumped 42% and 58% Last Week: Can They Still Climb Higher? ↗

April 17, 2023

Good news drove shares of these stocks through the roof last week, but investors should be more concerned about their paths forward.

Via The Motley Fool

Why Shares of Sana Biotechnology Jumped This Week ↗

April 14, 2023

The company announced details of research on two of its pre-clinical therapies.

Via The Motley Fool

Why Sana Biotechnology Shares Are Trading Higher Today ↗

April 13, 2023

Sana Biotechnology (NASDAQ: SANA) shares are trading higher after the company announced the publication of a paper in Nature Communications on hypoimmune-modified allogeneic CD19-directed CAR T cells.

Via Benzinga

Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday ↗

April 13, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Sana Biotechnology Announces Preclinical Data Published in Nature Communications Demonstrating the Ability of its Hypoimmune Allogeneic CD19-directed CAR T Cells to Evade Immune Rejection and Produce Durable Anti-Tumor Responses

April 13, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Morgan Stanley Maintains Overweight Rating for Sana Biotechnology: Here's What You Need To Know ↗

January 24, 2023

Via Benzinga

Sana Biotechnology Outlines Pipeline Prioritization, Reduces Workforce ↗

November 30, 2022

Via Benzinga

Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 13, 2023

Gainers CXApp Inc. (NASDAQ: CXAI) jumped 105% to $3.28 after climbing over 20% on Wednesday.

Via Benzinga

Sana Biotechnology Announces Preclinical Data Published in Science Translational Medicine Showing its Hypoimmune Pancreatic Islet Cells Evaded Allogeneic and Autoimmune Rejection and Controlled Type 1 Diabetes in Preclinical Model

April 12, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces the Appointment of Two Pioneers in Drug Discovery and Development to Lead its R&D Organization

April 10, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates

March 16, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces the Acceptance of Four Abstracts for Presentation at the 2023 American Association for Cancer Research Annual Meeting

March 14, 2023

Late-breaking poster presentation to highlight preclinical data demonstrating that the increased potency of CD8-targeted fusosomes enhances CAR gene delivery to resting primary T cells

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at the Cowen 43rd Annual Health Care Conference

March 01, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at the Guggenheim Healthcare Talks 5th Annual Oncology Conference

February 02, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-targeted Allogeneic CAR T Therapy for Patients with B-Cell Malignancies

January 26, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Wednesday ↗

December 28, 2022

On Wednesday, 258 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

December 19, 2022

On Monday, 297 companies reached new 52-week lows.

Via Benzinga

Sana Biotechnology Highlights Hypoimmune Allogeneic CAR T Cell Programs and in vivo Technology Platform with Six Presentations at 2022 ASH Annual Meeting

December 11, 2022

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Confirms Key Program Timelines and Announces Portfolio Prioritization

November 29, 2022

From Sana Biotechnology, Inc

Via GlobeNewswire

Vodafone, Getty Images Holdings, Haynes International And Some Other Big Stocks Moving Lower On Tuesday ↗

November 15, 2022

U.S. stocks traded higher, with the Nasdaq gaining more than 200 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Sana Biotechnology Tops BioSpace’s 2023 Best Places to Work Ranking in Small Employer Category

November 14, 2022

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces Several Preclinical Data Presentations at the 64th American Society of Hematology Annual Meeting

November 03, 2022

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Reports Third Quarter 2022 Financial Results and Business Updates

November 02, 2022

From Sana Biotechnology, Inc

Via GlobeNewswire

7 Unknown Biotech Stocks That Could Rocket in 2023 ↗

September 23, 2022

Unknown biotech stocks that are poised for a big rally in 2023. Emerging biotech companies with a promising clinical pipeline.

Via InvestorPlace

7 Stocks Due for a Stunning Short Squeeze ↗

August 09, 2022

If you can handle the heat, these ideas could potentially cook up some massive profits.

Via InvestorPlace

This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday ↗

July 25, 2022

Gainers

Via Benzinga

DocuSign CEO Shuffle: Why One Analyst Remains On The Sidelines For Now ↗

June 22, 2022

After a horrendous year for Docusign Inc (NASDAQ: DOCU), the company made a major announcement this week that CEO Dan Springer will be stepping down.

Via Benzinga

21 Stocks Moving in Wednesday's Pre-Market Session ↗

June 22, 2022

Gainers Codex DNA, Inc. (NASDAQ: DNAY) rose 64.5% to $3.52 in pre-market trading after declining 10% on Tuesday.

Via Benzinga

89 Biggest Movers From Friday ↗

June 21, 2022

Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.